Skip to main content
VIB.BE
en
  • English
  • Dutch
About
Home
  • Research & Impact
    • Research Areas
      • Immunity & Inflammation
      • Cancer Research
      • Medical Biotechnology
      • Neuroscience
      • Plant Biology
      • Microbiology
      • Structural Biology
      • Computational Biology
    • Research Centers
      • Center for Cancer Biology
      • VIB.AI: Center for AI & Computational Biology
      • Center for Inflammation Research
      • Center for Medical Biotechnology
      • Center for Microbiology
      • Center for Molecular Neurology
      • Center for Structural Biology
      • Center for Plant Systems Biology
      • VIB-KU Leuven Center for Neuroscience
    • Grand Challenges
      • Selected projects
      • Societal impact
      • Upcoming call
      • Modalities
      • Contact
    • Translational Research
    • Research Impact
      • IPBO
      • Biotech for security and public health resilience
      • Aureus Nova Scientia Prize
    • Publications
    • Responsible Research
      • Why animal research is necessary
    • Research Infrastructure
      • ESFRI
  • Business
    • Business Development
      • VIB’s Business Development team
      • Technology transfer
    • New Ventures
      • From idea to spin-off
      • Embarking on a long-term adventure
      • VIB's Spin-offs
    • Intellectual Property
    • Ecosystem
      • Biotope
    • Discovery Sciences
      • Internship program
    • AI Studio
    • Success Stories
      • Towards a COVID-19 Drug
      • Revolutionary diagnostic cancer test
      • On the road to new asthma therapeutics
      • Antibodies for piglets
      • Agribiotech cluster in Ghent
      • Blood test for liver diseases
      • Safe test for mother and child
      • Toward new cancer medicines
      • Experimental micro-brewery of VIB and KU Leuven
      • Nanobodies, our legacy
      • DNA sequencing tools with our technology
    • Facilities
  • Technologies
    • Tech Portfolio
      • Bioimaging
      • Flow cytometry
      • Metabolomics
      • Nanobody production
      • Nucleomics
      • Protein production
      • Proteomics
      • Research data services
      • Screening
      • Single cell technology
      • Technology scouting
      • Spatial Catalyst
    • About VIB technologies
      • Our dual mission
      • Meet our experts
      • Technology Training
      • Jobs
      • Core for Life
      • Partner with VIB Technologies
  • Public Outreach
    • Facts Series
    • Educational Projects
    • Events
  • News
    • Press
    • Called to Science
    • VIBTimes
    • Blog
    • In the spotlight
      • VIB Microbes
      • VIB Lessons from Plants
      • VIB Technologies
      • Neuroscience
  • Training & Conferences
    • Partner events
  • Careers
    • Jobs
    • Why VIB?
    • DE&I
    • Supporting your journey
    • Grants Office
    • Why Flanders?
  • Research & Impact
    • Research Areas
      • Immunity & Inflammation
      • Cancer Research
      • Medical Biotechnology
      • Neuroscience
      • Plant Biology
      • Microbiology
      • Structural Biology
      • Computational Biology
    • Research Centers
      • Center for Cancer Biology
      • VIB.AI: Center for AI & Computational Biology
      • Center for Inflammation Research
      • Center for Medical Biotechnology
      • Center for Microbiology
      • Center for Molecular Neurology
      • Center for Structural Biology
      • Center for Plant Systems Biology
      • VIB-KU Leuven Center for Neuroscience
    • Grand Challenges
      • Selected projects
      • Societal impact
      • Upcoming call
      • Modalities
      • Contact
    • Translational Research
    • Research Impact
      • IPBO
      • Biotech for security and public health resilience
      • Aureus Nova Scientia Prize
    • Publications
    • Responsible Research
      • Why animal research is necessary
    • Research Infrastructure
      • ESFRI
  • Business
    • Business Development
      • VIB’s Business Development team
      • Technology transfer
    • New Ventures
      • From idea to spin-off
      • Embarking on a long-term adventure
      • VIB's Spin-offs
    • Intellectual Property
    • Ecosystem
      • Biotope
    • Discovery Sciences
      • Internship program
    • AI Studio
    • Success Stories
      • Towards a COVID-19 Drug
      • Revolutionary diagnostic cancer test
      • On the road to new asthma therapeutics
      • Antibodies for piglets
      • Agribiotech cluster in Ghent
      • Blood test for liver diseases
      • Safe test for mother and child
      • Toward new cancer medicines
      • Experimental micro-brewery of VIB and KU Leuven
      • Nanobodies, our legacy
      • DNA sequencing tools with our technology
    • Facilities
  • Technologies
    • Tech Portfolio
      • Bioimaging
      • Flow cytometry
      • Metabolomics
      • Nanobody production
      • Nucleomics
      • Protein production
      • Proteomics
      • Research data services
      • Screening
      • Single cell technology
      • Technology scouting
      • Spatial Catalyst
    • About VIB technologies
      • Our dual mission
      • Meet our experts
      • Technology Training
      • Jobs
      • Core for Life
      • Partner with VIB Technologies
  • Public Outreach
    • Facts Series
    • Educational Projects
    • Events
  • News
    • Press
    • Called to Science
    • VIBTimes
    • Blog
    • In the spotlight
      • VIB Microbes
      • VIB Lessons from Plants
      • VIB Technologies
      • Neuroscience
  • Training & Conferences
    • Partner events
  • Careers
    • Jobs
    • Why VIB?
    • DE&I
    • Supporting your journey
    • Grants Office
    • Why Flanders?
  • Log in
en
  • English
  • Dutch
About

The Liver Project

Overcoming the main current diagnostic challenges in hepatology practice in the liver project.
The Liver Project

PID Results

PID Results

IBCORI Results

IBCORI Results

PID Team

PID Team

PID Project

The VIB-Grand Challenges primary immune deficiency (PID)-consortium will address the urgent need for mechanistic understanding and molecular diagnostic tools to better stratify PID patients and guide therapeutic decisions in the clinic.
PID Project

Pagination

  • First page ‹‹
  • Previous page ‹
  • …
  • Page 35
  • Page 36
  • Current page 37
  • Page 38
  • Page 39
  • …
  • Next page ›
  • Last page ››

Footer

Keep me informed about VIB news and events
Home
  • Contact
  • Donate
  • Sitemap

VIB

Suzanne Tassierstraat 1
9052 Ghent
Belgium

BE 0456 343 923

+32 9 244 66 11info@vib.be

Follow us

facebook
instagram
bluesky
youtube
linkedin
vimeo
  • © VIB
  • Cookie policy
  • Disclaimer
  • Privacy
Administrator login Cookie preferences